Table 2.
LISA study participants mortality outcomes as of June 30, 2017 (n = 910)
| Variable | Alive (n = 716) | Died (n = 194) | p-value |
|---|---|---|---|
| Age, at survey | |||
| Median (Q1, Q3) | 45 (39, 50) | 47 (41, 53) | 0.001* |
| Calendar year of ART initiation | 0.149 | ||
| < 1996 | 29 (4.1%) | < 5a | |
| 1996–2004 | 419 (58.5%) | 124 (63.9%) | |
| > 2004 | 268 (37.4%) | 65–70a | |
| Gender | |||
| Women | 197 (27.5%) | 60 (30.9%) | 0.349 |
| Men | 519 (72.5%) | 134 (69.1%) | |
| Ethnicity | |||
| White/Caucasian | 474 (66.2%) | 117 (60.3%) | 0.009* |
| Asian | 20 (2.8%) | < 5a | |
| Indigenous | 180 (25.2%) | 69 (35.6%) | |
| Other | 42 (5.9%) | < 5a | |
| Current tobacco use | |||
| Yes | 442 (62.0%) | 154 (79.8%) | < 0.001* |
| No | 271 (38.0%) | 39 (20.2%) | |
| Current excessive alcohol use (CAGE) | < 0.001* | ||
| Yes | 338 (47.7%) | 121 (63.4%) | |
| No | 370 (52.3%) | 70 (36.6%) | |
| Current injection drug use | < 0.001* | ||
| Yes | 137 (19.2%) | 65 (33.7%) | |
| No | 576 (80.8%) | 128 (66.3%) | |
| Stable housing | |||
| Yes | 519 (72.6%) | 101 (52.1%) | < 0.001* |
| No | 196 (27.4%) | 93 (47.9%) | |
| Food security | |||
| Yes | 258 (36.1%) | 46 (23.8%) | 0.001* |
| No | 456 (63.9%) | 147 (76.2%) | |
| Location of residence | |||
| Rural | 20 (2.8%) | < 5a | |
| Urban/Suburban | 686 (97.2%) | 185–195 | 0.443 |
| CD4 cell count at ART initiation | |||
| cells/mm3 | 370 (240, 540) | 270 (180, 450) | < 0.001* |
Median (Q1, Q3) or n (%) presented
*indicates statistical significance at p ≤ 0.05
a For confidentiality and disclosure control measures, exact counts for cells with values n < 5 were suppressed. In accordance with strategies employed by Lofters et al. [30], if only one cell was n < 5 then one additional category is masked by providing a range (with no percentages available). Disclosure controls are only applied for descriptive tabulations and exact counts were used for analyses